ENTITY
BioNTech

BioNTech (BNTX US)

49
Analysis
Health Care • Germany
BioNTech SE provides biotechnological solutions. The Company develops various types of treatments for cancer patients' tumors. BioNTech serves customers worldwide.
more
Exchange Announcement • 04 Dec 2025 05:32

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Exchange Announcement • 27 Nov 2025 05:34

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Exchange Announcement • 15 Nov 2025 05:15

424B3 | Prospectus

Exchange Announcement • 12 Nov 2025 21:01

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Exchange Announcement • 12 Nov 2025 21:00

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

x